Healthcare & Life Sciences
Syntimmune
United Statessyntimmune.com
Syntimmune is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About Syntimmune
Syntimmune is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Syntimmune is a clinical-stage biopharmaceutical company that develops novel antibody-based therapies targeting autoimmune and immunological diseases, including rare diseases such as amyloidosis.
Explore Syntimmune's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.